Publication | Open Access

A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405

Elderly PatientsMedicinePharmacologyPhase Ii StudyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologySmall-cell Lung CancerLung Cancer